BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 7982254)

  • 1. A comparison of ampicillin/sulbactam and cefuroxime in the treatment of patients with bacterial infections of the lower respiratory tract.
    Geckler RW
    Clin Ther; 1994; 16(4):662-72. PubMed ID: 7982254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sulbactam/ampicillin in comparison with cefuroxime for infections of the lower respiratory tract. Results of a prospective, randomized comparative study].
    Schwigon CD; Cuhorst R; Gabor M; Zinndorf J; Springsklee M
    Med Klin (Munich); 1993 Jan; 88(1):16-20. PubMed ID: 8437527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
    Jauregui L; Minns P; Hageage G
    Adv Ther; 1995; 12(1):62-71. PubMed ID: 10150322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of chemoprophylaxis against Enterococcus species in elective cholecystectomy: a randomized study of cefuroxime vs ampicillin-sulbactam.
    Dervisoglou A; Tsiodras S; Kanellakopoulou K; Pinis S; Galanakis N; Pierakakis S; Giannakakis P; Liveranou S; Ntasiou P; Karampali E; Iordanou C; Giamarellou H
    Arch Surg; 2006 Dec; 141(12):1162-7. PubMed ID: 17178957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of ampicillin/sulbactam and cefoxitin in the treatment of bacterial skin and skin-structure infections.
    Weigelt JA
    Adv Ther; 1994; 11(4):183-91. PubMed ID: 10150262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulbactam/ampicillin combination in the treatment of acute and chronic lower respiratory infections.
    Bisetti A; Grassi L; Scacciacillani E; Putti P
    J Int Med Res; 1991; 19 Suppl 1():36A-43A. PubMed ID: 2060692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Italian experience of sequential intravenous and oral azithromycin plus intravenous ampicillin/sulbactam in hospitalized patients with community-acquired pneumonia.
    Todisco T; Dal Farra F; Ciliberti G; Pirina P; Guelfi R; Serra G; Paris R; Mancuso I; Cepparulo M
    J Chemother; 2008 Apr; 20(2):225-32. PubMed ID: 18467250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibiotic prophylaxis in cardiovascular surgery: comparison of sulbactam-ampicillin and cefuroxime].
    Girotto M; Comoglio C; Donegani E; Di Summa M
    Riv Eur Sci Med Farmacol; 1993; 15(1):43-6. PubMed ID: 8159835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An open comparative study of sulbactam/ampicillin vs mezlocillin in adult and pediatric patients. Efficacy and tolerability].
    Chiodo F; Manfredi R; Zucchini A
    Minerva Med; 1991 Jun; 82(6):387-94. PubMed ID: 2067712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection].
    Gao B; Hu J; Deng W
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):528-31. PubMed ID: 11360502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse.
    Talan DA; Summanen PH; Finegold SM
    Clin Infect Dis; 2000 Aug; 31(2):464-71. PubMed ID: 10987706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients. UNASYN Pediatric Study Group.
    Azimi PH; Barson WJ; Janner D; Swanson R
    Pediatr Infect Dis J; 1999 Jul; 18(7):609-13. PubMed ID: 10440436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia.
    Betrosian AP; Frantzeskaki F; Xanthaki A; Douzinas EE
    J Infect; 2008 Jun; 56(6):432-6. PubMed ID: 18501431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-agent therapy for acute pelvic inflammatory disease: sulbactam/ampicillin versus cefoxitin.
    Hemsell DL; Bawdon RE; Hemsell PG; Nobles BJ; Heard MC
    J Int Med Res; 1990; 18 Suppl 4():85D-89D. PubMed ID: 2282973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ampicillin/sulbactam versus cefazolin or cefoxitin in the treatment of skin and skin-structure infections of bacterial etiology.
    Chan JC
    Adv Ther; 1995; 12(2):139-46. PubMed ID: 10150324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sultamicillin experiences in the field of internal medicine.
    Hara K; Kobayashi H
    APMIS Suppl; 1989; 5():51-6. PubMed ID: 2660872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of sulbactam/ampicillin in the treatment of moderately severe bacterial infections.
    Fong KY; Howe HS; Boey ML; Feng PH
    Singapore Med J; 1989 Apr; 30(2):170-2. PubMed ID: 2609176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical results with sulbactam/ampicillin in a multicenter study of 425 patients].
    Lode H; Springsklee M
    Med Klin (Munich); 1989 May; 84(5):236-41. PubMed ID: 2661984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
    Jauregui L; Minns P; Hageage G
    J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ampicillin/sulbactam vs. clindamycin/gentamicin in the treatment of postpartum endometritis.
    Gall S; Koukol DH
    J Reprod Med; 1996 Aug; 41(8):575-80. PubMed ID: 8866384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.